ESMO 2020 Archives - Medical Conferences

Home > Oncology > ESMO 2020

Read the full Report (pdf)

European Society for Medical Oncology 19-21 September 2020

Featured articles

Letter from the Editor

Editor

Dr Stefan Rauh, Centre Hospitalier Emile Mayrisch, Luxembourg

Conference

ESMO 2020

25 November 2020 17:00

COVID-19 and Cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 16:22

ESMO 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ESMO 2020

23 September 2020 12:53

Online First

COVID-19 and Cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 16:22

Breast Cancer

CDK4/6 inhibition in high-risk early breast cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 16:20

Neoadjuvant treatment in patients with high-risk early breast cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 16:19

Prognostic value of tumour infiltrating lymphocytes in young TNBC patients

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 16:16

Contradicting results for chemoimmunotherapy in metastatic TNBC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 16:01

Second-line sacituzumab govitecan improves survival in metastatic TNBC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:14

Gastrointestinal Cancers

Rechallenge of RAS/BRAF wildtype CRC with avelumab plus cetuximab

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:13

Surveillance after curative treatment for CRC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:11

Adjuvant chemotherapy less effective in elderly CRC patients

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:10

Nivolumab plus chemotherapy: new standard for first-line treatment of gastric cancer?

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:08

Lung Cancer

Preoperative immunotherapy in early stage NSCLC safe and feasible

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:07

No advantage of post-operative radiotherapy in patients with stage IIIA N2 NSCLC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:06

Adjuvant osimertinib in NSCLC reduces risk of CNS recurrence

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:05

Lorlatinib outperforms crizotinib in ALK-positive advanced NSCLC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:02

First-line immune checkpoint inhibition in metastatic NSCLC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 15:00

PD-L1 density, a new predictive biomarker in NSCLC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:59

Atezolizumab/bevacizumab for non-squamous NSCLC with high PD-L1 expression

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:58

Consolidation ipilimumab and nivolumab in limited stage SCLC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:56

Melanoma

Adjuvant immune checkpoint inhibition after complete resection

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:55

Immuno-combination therapy in metastatic melanoma

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:52

Genitourinary Cancers

Abiraterone in M1 hormone-naïve prostate cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:51

New treatment option for patients with mCRPC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:50

First-line treatment of advanced/metastatic RCC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:44

First-line immune-combination therapies in mUC

Trial

Phase 3, KEYNOTE-361

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:43

Second- and third-line treatment options in mUC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:41

Bladder cancer risk and early detection

Presented By

Dr Thibault De La Motte Rouge, Dr Wei Shen Tan, Dr Bas van Rhijn, Dr Francesco Soria

Trial

EDIFICE 6, DETECT 1

Conference

EAU 2019

Type

Peer-reviewed article

21 May 2019 22:44

Gynaecological Cancers

Treatment of newly diagnosed ovarian cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:39

Treatment of recurrent ovarian cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:35

Palbociclib effective in ER-positive endometrial cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:23

Basic Science

Bispecific antibodies targeting PD-1 and CTLA-4: new kids on the block(ade)

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 12:45

PD-(L)1, LAG-3, and TIM blockade

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 12:43

CRC disseminates using collective migration

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 12:30

Featured articles

CONTENTS

Online First

COVID-19 and Cancer

Breast Cancer

Gastrointestinal Cancers

Lung Cancer

Melanoma

Genitourinary Cancers

Gynaecological Cancers

Basic Science